Author

M. Rodionov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Belogurov· 1 shared A. Chernov· 1 shared A. Gabibov· 1 shared A. Kudriaeva· 1 shared F. Mesheryakov· 1 shared G. Telegin· 1 shared K. Ivanova· 1 shared V. Kazakov· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Belogurov

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model of the SARS-CoV-2-related acute respiratory distress syndrome

A. Chernov, M. Rodionov, V. Kazakov, K. Ivanova, F. Mesheryakov, A. Kudriaeva, A. Gabibov, G. Telegin, A. Belogurov

This paper shows that TAK-779, a CCR5/CXCR3 antagonist, prevents diffuse alveolar damage in a murine model of SARS-CoV-2-induced ARDS by reducing mononuclear infiltration and cytokine levels.

bioRxiv · Nov 14, 2023Pathology